Could CBD Help Treat Fentanyl Addiction? A Look at Early Research

Augusta University researchers are studying inhaled CBD and the opioid crisis.

Researchers at Augusta University have been exploring an unconventional idea in the fight against the opioid crisis: whether inhaled cannabidiol (CBD) — a non-psychoactive compound from cannabis — could help address fentanyl addiction. Their research has drawn attention for a novel angle, focusing not on opioid receptors but on inflammation in the brain.

Fentanyl is a synthetic opioid up to 100 times more potent than morphine, and it has been a central driver of the opioid epidemic, linked to more than 250,000 deaths in the U.S. since 2018. Existing treatments for opioid addiction typically target the brain's opioid receptors and are most effective alongside psychosocial therapy and professional supervision — support that isn't equally accessible everywhere, particularly in rural areas. That accessibility gap is part of what motivated the search for new approaches.

What the Research Found

The study, led by Dr. Babak Baban and Dr. Phillip Wang, worked with mice. The researchers observed that fentanyl exposure increased inflammation in the brain and altered immune cells involved in the brain's inflammatory response. Their hypothesis was that this neuroinflammation plays a role in how addiction develops and persists — and that targeting it might help.

When they administered inhaled CBD to mice that had developed fentanyl addiction, they reported that the CBD treatment reduced the elevated brain inflammation and lessened a number of addiction-related behaviors. The team's conclusion was that inhaled CBD could help regulate neuroinflammatory responses associated with fentanyl addiction, and that the approach is non-invasive and warrants further research.

Reading This Research Responsibly

This is a genuinely interesting line of inquiry, but a few things are essential to understand before drawing any conclusions:

• It's an animal study. The findings come from mice. Results in animals frequently do not carry over to humans, and the researchers themselves call for human studies to validate the work.
• It's a preprint, not a peer-reviewed publication. The study was posted to bioRxiv, a preprint server. That makes it publicly available, but it has not been through the independent peer-review process that published journal articles undergo.
• There is a commercial interest to disclose. Several of the researchers are affiliated with a cannabis company, and the company that supplied the CBD inhalers has a licensing contract with the university. This doesn't invalidate the work, but it's relevant context.

None of this means the research isn't worthwhile — early, exploratory studies like this are how new treatments begin. But it does mean inhaled CBD is not a treatment for fentanyl addiction today, and no one should approach it as one.

If You or Someone You Know Is Struggling

Fentanyl addiction is life-threatening, and effective, evidence-based treatments exist right now. If you or someone you care about is struggling with opioid use, please reach out to a healthcare provider or a dedicated support service. In the U.S., the SAMHSA National Helpline (1-800-662-4357) offers free, confidential help 24/7. Please don't wait for future research — support is available today.

Reference: Bhandari B, Chagas HIS, et al. Cannabidiol reverses fentanyl-induced addiction and modulates neuroinflammation. bioRxiv preprint, posted July 2024. DOI: 10.1101/2024.07.20.604441. Note: this is a preprint and has not been certified by peer review.

This article is for general information only and is not medical advice. Inhaled CBD is not an approved treatment for fentanyl or any opioid addiction. If you are struggling with opioid use, please consult a qualified healthcare professional.